These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30248063)

  • 41. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy.
    Miwa H; Mizuno Y
    Acta Neurol Scand; 2002 Oct; 106(4):209-12. PubMed ID: 12225316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
    Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
    Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
    Wenning GK; Colosimo C
    Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
    Santiago JA; Potashkin JA
    PLoS One; 2015; 10(11):e0142582. PubMed ID: 26566043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive supranuclear palsy.
    Rehman HU
    Postgrad Med J; 2000 Jun; 76(896):333-6. PubMed ID: 10824045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potential significance of hepcidin evaluation in progressive supranuclear palsy.
    Alster P; Otto-Ślusarczyk D; Wiercińska-Drapało A; Struga M; Madetko-Alster N
    Brain Behav; 2024 Jun; 14(6):e3552. PubMed ID: 38953731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low serum uric acid levels in progressive supranuclear palsy.
    Oropesa-Ruiz JM; Huertas-Fernández I; Jesús S; Cáceres-Redondo MT; Vargas-Gonzalez L; Carrillo F; Carballo M; Gómez-Garre P; Mir P
    Mov Disord; 2016 Mar; 31(3):402-5. PubMed ID: 26686202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
    Altiparmak UE; Eggenberger E; Coleman A; Condon K
    J Neuroophthalmol; 2006 Dec; 26(4):257-9. PubMed ID: 17204917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
    Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
    Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentration of neural thread protein in cerebrospinal fluid from progressive supranuclear palsy and Parkinson's disease.
    Yamada T; Chong JK; Asahina M; Koguchi Y; Hirayama K
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):631-5. PubMed ID: 8301879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
    Kroonenberg PM; Oort FJ; Stebbins GT; Leurgans SE; Cubo E; Goetz CG
    BMC Med Res Methodol; 2006 Jun; 6():26. PubMed ID: 16772027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.
    Aarsland D; Litvan I; Larsen JP
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):42-9. PubMed ID: 11207328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.